Ionis nimmt an vier Investorenkonferenzen teil

• Ionis Pharmaceuticals nimmt mit dem Management an vier Investorenkonferenzen im November und Dezember 2026 teil.
• Auftakt bei der UBS Global Biopharma Conference am 16. November 2026; anschliessend Jefferies Global Healthcare Conference am 18. November 2026.
• Weitere Kamingespräche bei Citi's 2026 Global Healthcare Conference am 1. Dezember 2026 sowie Piper Sandler 38th Annual Healthcare Conference am 2. Dezember 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ionis Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261110915887) on November 10, 2026, and is solely responsible for the information contained therein.